STOCK TITAN

ADM Tronics flags going-concern doubt despite profit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

ADM Tronics Unlimited, Inc. (ADMT) reported third-quarter revenue of $941,671, up 6.1%, and net income of $140,661 versus a $114,672 loss a year earlier. Gross profit was $508,888 versus $375,797, and gross margin was 54% versus 42%. Six-month revenue was $1,807,926, down 2.9%; pretax income was $175,025 versus $214,462, including $59,250 of unrealized investment gains, which were not cash.

Operating cash flow used $51,320 over six months; cash was $204,410 as of September 30, 2026. Management disclosed substantial doubt about its ability to continue as a going concern for one year from November 16, 2026. Disclosure controls were not effective as of September 30, with inadequate accounting staffing and segregation of duties cited.

After quarter-end, a private placement targeted approximately $5.0 million gross and was to terminate no later than December 31, 2026. By October 28, 2026, the company had issued 15,500,000 shares and warrants for 7,750,000 shares for $1,550,000 gross proceeds. Shares and warrant exercise price were each $0.10; warrants are exercisable for five years. The board is to expand from one to five: Michael Burychka joined October 27, 2026, and Klaus Kleinfeld and Greg Wasson joined November 16, 2026; one seat is reserved for an independent director. The company said this reconstitution will result in a change in control.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue rose 6.1% to $941,671.
  • Moderate pointThird-quarter net income was $140,661, versus a $114,672 loss.

Negative

  • Major pointSubstantial doubt remains about going concern for one year from November 16, 2026.
  • Moderate pointDisclosure controls were not effective as of September 30, 2026.

Filing Explained

ADM Tronics agreed to reorganize its existing operations into a wholly owned subsidiary and fund it with up to $500,000 from placement proceeds; the expected initial $200,000 transfer to its operating account had not occurred by the report date.

Third-quarter revenue $941,671 Three months ended September 30, 2026; up 6.1% from the same period in 2025
Third-quarter net income $140,661 Three months ended September 30, 2026; prior-year period reported a net loss of $114,672
Third-quarter gross profit $508,888 Three months ended September 30, 2026; compared with $375,797 in 2025
Six-month revenue $1,807,926 Six months ended September 30, 2026; down 2.9% from the same period in 2025
Net cash used in operating activities $51,320 used Six months ended September 30, 2026
Private-placement gross proceeds $1,550,000 Proceeds from shares issued October 27 and 28, 2026
Private-placement target gross proceeds Approximately $5.0 million Placement agreement dated October 26, 2026
Private-placement securities issued 15,500,000 shares; warrants to purchase 7,750,000 shares Issued October 27 and 28, 2026
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
unrealized gains financial
"these unrealized gains are not a source of cash"
An unrealized gain is the increase in value of an asset you still own that hasn’t been sold, so the profit exists on paper but hasn’t been converted into cash. It matters to investors because it changes the apparent wealth of a portfolio and can influence decisions about selling, risk-taking and taxes—like a house that’s worth more now but won’t pay you until you sell it.
operating cash flow financial
"Operating cash flow for the current period"
Operating cash flow is the amount of money a company earns from its main business activities, like selling products or services. It shows how well the company can generate cash to pay bills, invest in growth, or return money to shareholders. This figure helps investors understand if the company’s core operations are healthy and sustainable.
warrants financial
"warrants are exercisable at $0.10 per share for five years"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
segregation of duties technical
"The inadequate segregation of duties is a weakness"
Segregation of duties is the practice of splitting important financial and operational tasks among different people so no single person can both start, approve, and record the same transaction — like having one person ring up sales and another person deposit the money. For investors, it matters because this simple separation reduces the chance of mistakes or fraud, helps ensure financial reports are trustworthy, and lowers legal and reputation risk that can affect a company’s value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were ADMT’s revenue and net income for the quarter ended September 30, 2026?

ADMT reported revenue of $941,671 and net income of $140,661 for the three months ended September 30, 2026. A year earlier, revenue was $887,498 and the company reported a net loss of $114,672.

How much had ADMT raised in its October 2026 private placement?

By October 28, 2026, ADMT had issued 15,500,000 shares and warrants to purchase 7,750,000 shares for $1,550,000 in gross proceeds. The placement targeted approximately $5.0 million in gross proceeds and was to terminate no later than December 31, 2026.

Why did ADMT disclose substantial doubt about its ability to continue as a going concern?

The company reported operating losses and negative cash flows from operating activities. As of September 30, 2026, its accumulated deficit was $32,897,569 and cash used in operating activities was $51,320. Management cited plans involving existing resources, revenue growth and orders in the pipeline, while stating substantial doubt remained about the success of its funding plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Q2 2026 --03-31 false 0000849401 false false false false 5 2022 2023 2024 2025 2026 2023 2024 2025 2026 http://fasb.org/us-gaap/2026#DomesticCountryMember 0 0 3 1 2 2 2 3 2 2 1 0.00 0 0 2022 2023 2024 2025 2026 2023 2024 2025 2026 0 0 0 0 7 5 0 0 0 0 0.01 0.01 00008494012026-04-012026-09-30 thunderdome:item iso4217:USD 0000849401us-gaap:SubsequentEventMember2026-10-262026-10-28 0000849401srt:MaximumMemberus-gaap:SubsequentEventMember2026-10-262026-10-28 0000849401us-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-10-272026-10-28 xbrli:shares 0000849401admt:PrivatePlacementWarrantsMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-10-28 0000849401us-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-10-262026-10-26 utr:Y 0000849401admt:PrivatePlacementWarrantsMemberus-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-10-26 iso4217:USDxbrli:shares 0000849401us-gaap:SubsequentEventMemberus-gaap:PrivatePlacementMember2026-10-26 0000849401us-gaap:StateAndLocalJurisdictionMemberus-gaap:NewJerseyDivisionOfTaxationMember2026-04-012026-09-30 0000849401us-gaap:DomesticCountryMember2026-04-012026-09-30 00008494012025-04-012025-09-30 00008494012025-09-30 00008494012026-09-30 00008494012025-06-30 00008494012026-06-30 0000849401us-gaap:NewJerseyDivisionOfTaxationMember2025-04-012025-09-30 0000849401us-gaap:NewJerseyDivisionOfTaxationMember2026-04-012026-09-30 xbrli:pure 00008494012026-04-012026-06-30 0000849401us-gaap:StateAndLocalJurisdictionMember2026-09-30 0000849401us-gaap:DomesticCountryMember2026-09-30 0000849401us-gaap:DomesticCountryMember2025-09-30 0000849401us-gaap:StateAndLocalJurisdictionMember2025-09-30 0000849401us-gaap:FairValueMeasurementsRecurringMember2026-09-30 0000849401us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0000849401us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0000849401us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 00008494012026-03-31 0000849401admt:DefinedContribution401kRetirementPlanMember2026-04-012026-09-30 0000849401us-gaap:RevolvingCreditFacilityMember2026-03-31 0000849401us-gaap:RevolvingCreditFacilityMember2026-09-30 0000849401us-gaap:RevolvingCreditFacilityMember2021-09-072021-09-07 0000849401us-gaap:RevolvingCreditFacilityMember2018-06-15 00008494012025-07-012025-09-30 00008494012026-07-012026-09-30 0000849401admt:EngineeringServicesMemberadmt:QolMember2026-03-31 0000849401admt:EngineeringServicesMemberadmt:QolMember2026-09-30 0000849401admt:EngineeringServicesMemberadmt:QolMember2017-04-012018-03-31 0000849401us-gaap:NonUsMember2025-04-012025-09-30 0000849401us-gaap:NonUsMember2026-04-012026-09-30 0000849401admt:ChemicalMemberus-gaap:NonUsMember2025-04-012025-09-30 0000849401admt:ChemicalMemberus-gaap:NonUsMember2026-04-012026-09-30 0000849401country:US2025-04-012025-09-30 0000849401country:US2026-04-012026-09-30 0000849401admt:EngineeringMembercountry:US2025-04-012025-09-30 0000849401admt:EngineeringMembercountry:US2026-04-012026-09-30 0000849401admt:ElectronicsMembercountry:US2025-04-012025-09-30 0000849401admt:ElectronicsMembercountry:US2026-04-012026-09-30 0000849401admt:ChemicalMembercountry:US2025-04-012025-09-30 0000849401admt:ChemicalMembercountry:US2026-04-012026-09-30 0000849401us-gaap:NonUsMember2025-07-012025-09-30 0000849401us-gaap:NonUsMember2026-07-012026-09-30 0000849401admt:ChemicalMemberus-gaap:NonUsMember2025-07-012025-09-30 0000849401admt:ChemicalMemberus-gaap:NonUsMember2026-07-012026-09-30 0000849401country:US2025-07-012025-09-30 0000849401country:US2026-07-012026-09-30 0000849401admt:EngineeringMembercountry:US2025-07-012025-09-30 0000849401admt:EngineeringMembercountry:US2026-07-012026-09-30 0000849401admt:ElectronicsMembercountry:US2025-07-012025-09-30 0000849401admt:ElectronicsMembercountry:US2026-07-012026-09-30 0000849401admt:ChemicalMembercountry:US2025-07-012025-09-30 0000849401admt:ChemicalMembercountry:US2026-07-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:ForeignCustomersMember2025-04-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:ForeignCustomersMember2025-07-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:ForeignCustomersMember2026-04-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:ForeignCustomersMember2026-07-012026-09-30 0000849401admt:AccountsPayableBalanceMemberus-gaap:SupplierConcentrationRiskMemberadmt:OneVendorMember2025-04-012025-09-30 0000849401admt:AccountsPayableBalanceMemberus-gaap:SupplierConcentrationRiskMember2025-04-012025-09-30 0000849401admt:AccountsPayableBalanceMemberus-gaap:SupplierConcentrationRiskMemberadmt:TwoVendorsMember2026-04-012026-09-30 0000849401admt:AccountsPayableBalanceMemberus-gaap:SupplierConcentrationRiskMember2026-04-012026-09-30 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2025-04-012025-09-30 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-04-012025-09-30 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2025-04-012026-03-31 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-04-012026-03-31 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadmt:ThreeCustomersMember2026-04-012026-09-30 0000849401us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-04-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2025-04-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2025-07-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-04-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:CustomerTwoMember2025-04-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:CustomerOneMember2025-07-012025-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2026-04-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:TwoCustomersMember2026-07-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:OneCustomerMember2026-04-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberadmt:OneCustomerMember2026-07-012026-09-30 0000849401us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-04-012026-09-30 0000849401admt:SoftwareMember2026-03-31 0000849401admt:SoftwareMember2026-09-30 0000849401admt:PatentsAndTrademarksMember2026-03-31 0000849401admt:PatentsAndTrademarksMembersrt:MaximumMember2026-03-31 0000849401admt:PatentsAndTrademarksMembersrt:MinimumMember2026-03-31 0000849401admt:PatentsAndTrademarksMember2026-09-30 0000849401admt:PatentsAndTrademarksMembersrt:MaximumMember2026-09-30 0000849401admt:PatentsAndTrademarksMembersrt:MinimumMember2026-06-30 0000849401admt:LongTermMember2026-03-31 0000849401admt:CurrentMember2026-03-31 0000849401admt:LongTermMember2026-09-30 0000849401admt:CurrentMember2026-09-30 0000849401srt:MaximumMember2026-09-30 0000849401srt:MinimumMember2026-09-30 00008494012025-03-31 0000849401us-gaap:RetainedEarningsMember2026-09-30 0000849401us-gaap:AdditionalPaidInCapitalMember2026-09-30 0000849401us-gaap:CommonStockMember2026-09-30 0000849401us-gaap:RetainedEarningsMember2026-07-012026-09-30 0000849401us-gaap:RetainedEarningsMember2026-06-30 0000849401us-gaap:AdditionalPaidInCapitalMember2026-06-30 0000849401us-gaap:CommonStockMember2026-06-30 0000849401us-gaap:RetainedEarningsMember2026-04-012026-06-30 0000849401us-gaap:RetainedEarningsMember2026-03-31 0000849401us-gaap:AdditionalPaidInCapitalMember2026-03-31 0000849401us-gaap:CommonStockMember2026-03-31 0000849401us-gaap:RetainedEarningsMember2025-09-30 0000849401us-gaap:AdditionalPaidInCapitalMember2025-09-30 0000849401us-gaap:CommonStockMember2025-09-30 0000849401us-gaap:RetainedEarningsMember2025-07-012025-09-30 0000849401us-gaap:RetainedEarningsMember2025-06-30 0000849401us-gaap:AdditionalPaidInCapitalMember2025-06-30 0000849401us-gaap:CommonStockMember2025-06-30 00008494012025-04-012025-06-30 0000849401us-gaap:RetainedEarningsMember2025-04-012025-06-30 0000849401srt:RestatementAdjustmentMember2025-06-30 0000849401srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2025-06-30 0000849401us-gaap:RetainedEarningsMember2025-03-31 0000849401us-gaap:AdditionalPaidInCapitalMember2025-03-31 0000849401us-gaap:CommonStockMember2025-03-31 00008494012026-11-16
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from          to       

 

COMMISSION FILE NO. 0-17629

 

ADM TRONICS UNLIMITED, INC.
(Exact name of registrant as specified in its charter)

 

Delaware

(State or Other Jurisdiction

of Incorporation or organization)

22-1896032

(I.R.S. Employer

Identification Number)

 

224-S Pegasus Ave., Northvale, New Jersey 07647
(Address of Principal Executive Offices)

 

Registrant's Telephone Number, including area code: (201) 767-6040

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which

registered

None

N/A

N/A

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer  ☐

   

Non-accelerated filer ☒

Smaller reporting company ☒

   
 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

 

State the number of shares outstanding of each of the Issuer's classes of common equity, as of the latest practicable date:

 

The Company has 83,088,492 shares outstanding as of November 16, 2026.

 

 

  

 

ADM TRONICS UNLIMITED, INC.

 

INDEX

 

Part I - Financial Information

 
     

Item 1.

Condensed Financial Statements (unaudited):

 
     
 

Condensed Balance Sheets – September 30, 2026 (unaudited) and March 31, 2026

3

     
 

Condensed Statements of Operations for the three and six months ended September 30, 2026 and 2025 (unaudited)

4

     
 

Condensed Statements of Stockholders’ Equity for the three and six months ended September 30, 2026 and 2025 (unaudited)

5

     
 

Condensed Statements of Cash Flows for the six months ended September 30, 2026 and 2025 (unaudited)

6

     
 

Notes to Condensed Financial Statements

7

     

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

19

     

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

23

     

Item 4.

Controls and Procedures

24

     

Part II - Other Information

 
     

Item 1.

Legal Proceedings

 
     

Item 1A.

Risk Factors

25

     

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

25

     

Item 3.

Defaults Upon Senior Securities

25

     

Item 4.

Mine Safety Disclosures

25

     

Item 5.

Other Information

25

     

Item 6.

Exhibits

25

 

 

 

   

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. CONDENSED FINANCIAL STATEMENTS

 

ADM TRONICS UNLIMITED, INC.

CONDENSED BALANCE SHEETS 

 

   

September 30,

   

March 31,

 
   

2026

   

2026

 
   

(Unaudited)

         

ASSETS

               
                 

Current assets:

               

Cash and cash equivalents

  $ 204,410     $ 255,730  

Accounts receivable, net of credit losses of $975,597 at September 30, 2026 and March 31, 2026

    647,398       515,660  

Inventories

    370,951       250,624  

Prepaid expenses and other current assets

    14,248       -  
                 

Total current assets

    1,237,007       1,022,014  
                 

Other Assets:

               

Long-term inventory

    164,758       169,810  

Operating lease right-of-use asset

    175,098       222,313  

Loan receivable, net of allowance for doubtful accounts of $240,965 at September 30, 2026 and March 31, 2026.

    89,125       89,125  

Investments

    374,250       315,000  

Intangible assets, net of accumulated amortization of $45,336 and $42,059 at September 30, 2026 and March 31, 2026, respectively

    4,973       8,250  
                 

Total other assets

    808,204       804,498  
                 

Total assets

  $ 2,045,211     $ 1,826,512  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               
                 

Accounts payable

  $ 324,155     $ 251,089  

Bank overdraft

    162,816       133,885  

Accrued expenses and other current liabilities

    31,160       53,721  

Line of credit

    379,293       379,446  

Operating lease liability

    100,629       98,149  

Customer deposits

    144,875       130,022  
                 

Total current liabilities

    1,142,928       1,046,312  
                 

Long-term liabilities

               

Due to employee

    79,449       79,449  

Operating lease liability less current portion

    78,837       129,779  

Total long-term liabilities

    158,286       209,228  
                 

Total liabilities

    1,301,214       1,255,540  
                 

Stockholders' equity:

               

Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding

    -       -  

Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,492 shares issued and outstanding

    33,794       33,794  

Additional paid-in capital

    33,607,772       33,607,772  

Accumulated deficit

    (32,897,569 )     (33,070,594 )

Total stockholders' equity

    743,997       570,972  
                 

Total liabilities and stockholders' equity

  $ 2,045,211     $ 1,826,512  

 

See accompanying notes to the unaudited condensed financial statements

 

3

 

 

ADM TRONICS UNLIMITED, INC.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(Unaudited)

 

   

Three months ended

   

Six months ended

 
   

September 30,

   

September 30,

 
   

2026

   

2025

   

2026

   

2025

 
                                 

Net revenues

  $ 941,671     $ 887,498     $ 1,807,926     $ 1,861,173  
                                 

Cost of sales

    432,783       511,701       903,988       1,004,083  
                                 

Gross Profit

    508,888       375,797       903,938       857,090  
                                 

Operating expenses:

                               

Research and development

    121,546       96,740       224,813       222,329  

Selling, general and administrative

    240,692       276,504       553,130       522,974  
                                 

Total operating expenses

    362,238       373,244       777,943       745,303  
                                 

Income (loss) from operations

    146,650       2,553       125,995       111,787  
                                 

Other income (expense):

                               

Interest income

    1,791       1,434       3,680       3,255  

Interest and finance expenses

    (7,030 )     (7,659 )     (13,900 )     (15,330 )

Gain/(loss) from investment

    (750 )     (111,000 )     59,250       114,750  

Total other income (expense)

    (5,989 )     (117,225 )     49,030       102,675  
                                 

Income (loss) before provision for income taxes

    140,661       (114,672 )     175,025       214,462  
                                 

Provision for (benefit) income taxes:

                               

Current

    -       -       2,000       1,500  

Total provision (benefit) for income taxes

    -       -       2,000       1,500  
                                 

Net income (loss)

  $ 140,661     $ (114,672 )   $ 173,025     $ 212,962  
                                 

Basic and diluted per common share:

  $ 0.00     $ (0.00 )   $ 0.00     $ 0.00  
                                 

Weighted average shares of common stock outstanding - basic and diluted

    67,588,492       67,588,492       67,588,492       67,588,492  

 

See accompanying notes to the unaudited condensed financial statements

 

4

 

 

ADM TRONICS UNLIMITED, INC.

CONDENSED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(Unaudited)

 

   

Common Stock

   

Common Stock

   

Additional Paid-in

   

Accumulated

         
   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 
                                         

Balance at April 1, 2025

    67,588,492     $ 33,794     $ 33,607,772     $ (32,970,220 )   $ 671,346  
                                         

Prior period adjustment

                            (3,884 )     (3,884 )
                                         

Net income (loss)

                            327,634       327,634  
                                         

Balance at June 30, 2025

    67,588,492     $ 33,794     $ 33,607,772     $ (32,646,470 )   $ 995,096  
                                         

Net income (loss)

                            (114,672 )     (114,672 )
                                         

Balance at September 30, 2025

    67,588,492     $ 33,794     $ 33,607,772     $ (32,761,142 )   $ 880,424  
                                         

Balance at April 1, 2026

    67,588,492     $ 33,794     $ 33,607,772     $ (33,070,594 )   $ 570,972  
                                         

Net income (loss)

                            32,364       32,364  
                                         

Balance at June 30, 2026

    67,588,492     $ 33,794     $ 33,607,772     $ (33,038,230 )   $ 603,336  
                                         

Net income (loss)

                            140,661       140,661  
                                         

Balance at September 30, 2026

    67,588,492     $ 33,794     $ 33,607,772     $ (32,897,569 )   $ 743,997  

 

See accompanying notes to the unaudited condensed financial statements

 

5

 

 

ADM TRONICS UNLIMITED, INC.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(Unaudited)

 

   

September 30,

2026

   

September 30,

2025

 

Cash flows from operating activities:

               

Net income

  $ 173,025     $ 212,962  

Adjustments to reconcile net income (loss) to net cash used in operating activities:

               

Amortization

    3,277       3,465  

Write-off of inventories

    14,555       14,905  

Credit losses

    -       14,917  

Unrealized gain in investment

    (59,250 )     (114,750 )

Non-cash interest expense

    4,974       7,332  

Amortization of right-of-use asset

    47,215       44,856  

Changes in operating assets and liabilities balances:

               

Accounts receivable

    (131,738 )     (23,325 )

Inventories

    (129,830 )     (29,597 )

Prepaid expenses and other current assets

    (14,248 )     (4,468 )

Accrued interest on line of credit

    (153 )     2,433  

Accounts payable

    73,066       8,892  

Bank overdraft

    28,931       (61,165 )

Customer deposits

    14,853       (70,625 )

Accrued expenses and other current liabilities

    (22,561 )     (13,245 )

Payments of operating lease liability

    (53,436 )     (53,436 )

Net cash provided by (used in) operating activities

    (51,320 )     (60,849 )
                 

Cash flows provided (used) in financing activities:

               
Proceeds from line of credit     14,013       12,848  
Repayments of line of credit     (14,013 )     (12,848 )

Proceeds (payments) from/to PPP loan

    -       (896 )
                 

Net cash provided by (used in) financing activities

    -       (896 )
                 

Net increase (decrease) in cash and cash equivalents

    (51,320 )     (61,745 )
                 

Cash and cash equivalents - beginning of period

    255,730       382,969  
                 

Cash and cash equivalents - end of period

  $ 204,410     $ 321,224  
                 

Cash paid for:

               

Interest

  $ 14,053     $ 12,848  

Taxes

  $ 500     $ -  

 

See accompanying notes to the unaudited condensed financial statements

 

6

 

ADM TRONICS UNLIMITED, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

 

NOTE 1  - NATURE OF BUSINESS

 

ADM Tronics Unlimited, Inc. (“we”, “us”, the “Company” or “ADM”), was incorporated under the laws of the state of Delaware on November 24, 1969. We are a manufacturing and engineering concern whose principal lines of business are the design, manufacture, and sale of electronics of our own products or on a contract manufacturing basis; the production and sale of chemical and antistatic products; and, research, development and engineering services.

 

Electronic equipment is manufactured in accordance with customer specifications on a contract basis. Our electronic device product line consists principally of proprietary devices used in diagnostics and therapeutics of humans and animals and electronic controllers for spas and hot tubs. These products are sold to customers located principally in the United States. We are registered with the FDA as a contract manufacturing facility, and we manufacture medical devices for customers in accordance with their designs and specifications. Our chemical product line is principally comprised of water-based chemical products used in the food packaging and converting industries, and anti-static conductive paints, coatings and other products. These products are sold to customers located in the United States, Australia, Asia and Europe. We also provide research, development, regulatory, and engineering services to customers. Sonotron Medical Systems, Inc. (“SMI”), a former wholly owned subsidiary of ADM, had been inactive for several years and was dissolved during the fiscal year ended March 31, 2026. The dissolution of SMI had no material impact on the Company’s operations, financial position, or results of operations.

 

 

NOTE 2  - SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by ADM pursuant to accounting principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the condensed financial position and operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. These condensed financial statements should be read in conjunction with the audited financial statements and explanatory notes for the year ended March 31, 2026 as disclosed in our Annual Report on Form 10-K for that year. Unaudited interim results are not necessarily indicative of the results for the full fiscal year ending March 31, 2027. The balance sheet as of March 31, 2026 was derived from the audited financial statements as of and for the year then ended.

 

PRINCIPLES OF CONSOLIDATION

 

The financial statements include the accounts of ADM Tronics Unlimited, Inc. (the “Company”). Sonotron Medical Systems, Inc. (“SMI”), a formerly wholly owned subsidiary of ADM, was dissolved during the fiscal year ended March 31, 2026. The balances of SMI were merged into ADM prior to dissolution. As a wholly owned subsidiary, no adjustment to prior period comparative amounts was required.

 

7

 

USE OF ESTIMATES

 

These unaudited condensed financial statements have been prepared in accordance with GAAP and, accordingly, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our deferred tax assets and related valuation allowance, write down of inventory, impairment of long-lived assets, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates.

 

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.

 

CASH AND CASH EQUIVALENTS

 

Cash equivalents are comprised of highly liquid investments with original maturities of three months or less when purchased. We maintain our cash in bank deposit accounts, which at times, may exceed federally insured limits. We have not experienced any losses to date as a result of this policy. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of $250,000. At September 30, 2026, cash and cash equivalents were within the FDIC insured limit. At March 31, 2026, approximately $5,730 exceeded the FDIC limit. 

 

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The carrying amounts of accounts receivable is reduced by a valuation allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will be collected. Management provides for probable uncollectible amounts through a charge to expenses and a credit to a valuation allowance, based on its assessment of the current status of individual accounts. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable.

 

REVENUE RECOGNITION

 

ELECTRONICS:

 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90-day warranty on our electronics products and contract manufacturing, and a limited 5-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty expense included in sales of our electronic products has been de minimis. We have no other post shipment obligations. For contract manufacturing, revenues are recognized after shipments of the completed products.

 

Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately $40,000 and $73,000 as of March 31, 2026 were recognized as revenues during the three and six months ended September 30, 2026, respectively.

 

Customer deposits of approximately $58,000 and $100,000 as of March 31, 2025 were recognized as revenues during the three and six months ended September 30, 2025, respectively.

 

8

 

CHEMICAL PRODUCTS:

 

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

 

ENGINEERING SERVICES:

 

We provide certain engineering services, including research, development, quality control, and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services over time as the applicable performance obligations are satisfied.

 

All revenue is recognized net of discounts.

 

WARRANTY LIABILITIES

 

The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that no warranty liability is required as of the balance sheet dates. However, the Company periodically reviews the adequacy of its product warranties and will record an accrued warranty reserve if necessary.

 

INVENTORIES

 

Inventories are stated at the lower of cost (first-in, first-out method) and net realizable value. Inventories that are expected to be sold within one operating cycle (1 year) are classified as a current asset. Inventories that are not expected to be sold within 1 year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off based on prior and expected future usage.

 

Long-Term Inventory: Due to recent shortages of materials due to various issues, when an item the Company believes will be used in the future, even beyond the current fiscal year, becomes available, it will purchase as many items as management deems necessary to fulfill future orders.

 

PROPERTY AND EQUIPMENT

 

We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over five to seven years, the estimated useful lives of the property and equipment. As of September 30, 2026 and March 31, 2026, all fixed assets were fully depreciated.

 

INTANGIBLE ASSETS

 

Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount may not be recoverable. In reviewing for impairment, the Company compares the carrying value of the relevant asset to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and its carrying value. During the three and six months ended September 30, 2026 and 2025, there were no impairments.

 

ADVERTISING COSTS 

 

Advertising costs are expensed as incurred and amounted to $10,396 and $3,037 for the three months ended September 30, 2026 and 2025, respectively, and $15,896 and $5,047 for the six months ended September 30, 2026 and 2025, respectively.

 

SHIPPING AND HANDLING COSTS

 

Shipping and handling costs incurred for the three and six months ended September 30, 2026 were $3,897 and $5,573, respectively. Shipping and handling costs incurred for the three and six months ended September 30, 2025 were $4,635. Such costs are included in selling, general, and administrative expenses in the accompanying statements of operations.

 

9

 

INCOME TAXES

 

We report the results of our operations as part of our Federal tax return. Deferred income taxes result primarily from temporary differences between financial and tax reporting. Deferred tax assets and liabilities are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates. A valuation allowance is recorded to reduce a deferred tax asset to that portion that is expected to more likely than not be realized.

 

The Company has adopted the authoritative accounting guidance with respect to accounting for uncertainty in income taxes, which clarified the accounting and disclosures for uncertain tax positions related to income taxes recognized in the financial statements and addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended March 31, 2026 as follows:

 

Jurisdiction

Fiscal Year

Federal

2023 and beyond

New Jersey

2022 and beyond

 

There are currently no tax years under examination by any major tax jurisdictions.

 

The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of Selling, General and Administrative expense.

 

As of September 30, 2026, and 2025, the Company has no accrued interest or penalties related to uncertain tax positions.

 

NET EARNINGS PER SHARE

 

We compute basic earnings per share by dividing net income/loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. Common equivalent shares are excluded from the computation of net earnings per share if their effect is anti-dilutive.

 

There were zero (-0-) and 200,000 anti-dilutive instruments in force during the periods ended September 30, 2026 and 2025, respectively.

 

Per share basic and diluted income (loss) per share amounted to $0.00 and $(0.00) for the three months ended September 30, 2026 and 2025, respectively, and $0.00 and $0.00 for the six months ended September 30, 2026 and 2025, respectively.

 

10

 

LEASES

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changed financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis and a right-of-use asset, for the lease term. The Company adopted this guidance as of April 1, 2019, using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) the initial direct costs for any existing leases.

 

The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of twelve months or less and does not contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred.

 

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

 

NEW ACCOUNTING STANDARDS 

 

In June 2016, the FASB issued ASU 2016‑13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” This guidance affects entities holding financial assets and net investments in leases that are not measured at fair value through net income. The standard replaces the incurred loss model with the current expected credit loss (“CECL”) model, which requires organizations to measure all expected credit losses for financial instruments over their contractual life at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The Company adopted this standard effective April 1, 2024. The adoption of this standard did not have a material impact on the Company’s financial statements.

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This guidance enhances the transparency of income tax disclosures by requiring disaggregated information about a reporting entity’s effective tax rate reconciliation and the jurisdictions in which income taxes are paid. The Company adopted this guidance effective April 1, 2024. The Company has applied the provisions of this ASU prospectively, and the adoption has resulted in expanded disclosures in Note 14 to the financial statements.

 

In March 2024, the FASB issued ASU 2024-01, “Compensation—Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards.” This standard clarifies how an entity determines whether a profits interest or similar award is subject to the guidance in Topic 718. The Company adopted this guidance effective April 1, 2024. The adoption did not have a material impact on the Company’s financial statements.

 

The Company is currently evaluating the impact of other recently issued accounting pronouncements that are not yet effective but does not expect them to have a material impact on its financial statements upon adoption.

 

INVESTMENTS

 

Investments in publicly  held companies are recorded at fair value. 

 

Investments in privately held companies are valued at cost, net book value or fair value when available. Investments valued at cost or net book value is a departure from accounting principles generally accepted in the United States of America

 

GOING CONCERN

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced losses from operations and negative cash flows from operating activities, management has initiated several strategic plans to improve the Company's financial position. As of September 30, 2026, the Company had an accumulated deficit of $32,897,569 and cash used by operating activities of $51,320. Management's plans to address these conditions include leveraging existing resources and focusing on revenue growth and orders in the pipeline, which are expected to push the Company to profitability within the next fiscal year. 

 

11

 

There is substantial doubt that the funding plans will be successful and therefore the conditions discussed above have not been alleviated. As a result, there is substantial doubt about the Company’s ability to continue as a going concern for one year from November 16, 2026, the date the financial statements were available to be issued.

 

Our future capital requirements will depend upon many factors, including progress with developing, manufacturing and marketing our technologies, the time and costs involved in preparing, filing, prosecuting, maintaining and enforcing patent claims and other proprietary rights, our ability to establish collaborative arrangements, marketing activities and competing technological and market developments, including regulatory changes and overall economic conditions in our target markets. Our ability to generate revenue and achieve profitability requires us to successfully market and secure purchase orders for our products from customers currently identified in our sales pipeline as well as new customers. We also will be required to efficiently manufacture and deliver equipment on those purchase orders. These activities, including our planned research and development efforts, will require significant uses of working capital. There can be no assurances that we will generate revenue and cash flow as expected in our current business plan.

 

 

NOTE 3 - INVENTORIES        

 

Inventories at September 30, 2026 consisted of the following:

 

   

Current

   

Long Term

   

Total

 

Raw materials

  $ 260,055     $ 153,737     $ 413,792  

Finished goods

    110,896       11,021       121,917  

Totals

  $ 370,951     $ 164,758     $ 535,709  

 

Inventories at March 31, 2026 consisted of the following:

 

   

Current

   

Long Term

   

Total

 

Raw materials

  $ 205,379     $ 158,240     $ 363,619  

Finished goods

    45,245       11,570       56,815  

Totals

  $ 250,624     $ 169,810     $ 420,434  

  

 

NOTE 4 - INTANGIBLE ASSETS

 

   

September 30, 2026

   

March 31, 2026

 
   

Cost

   

Weighted

Average

Amortization

Period

(Years)

   

Accumulated Amortization

   

Net Carrying Amount

   

Cost

   

Weighted

Average

Amortization

Period

(Years)

   

Accumulated Amortization

   

Net Carrying Amount

 

Patents & Trademarks

  $ 35,794     10 - 15     $ (30,821 )   $ 4,973     $ 35,794     10 -  15     $ (29,959 )   $ 5,835  

Software

  $ 14,515     3     $ (14,515 )   $ -     $ 14,515       3       $ (12,100 )   $ 2,415  
                                                                 
    $ 50,309           $ (45,336 )   $ 4,973     $ 50,309               $ (42,059 )   $ 8,250  

 

Estimated aggregate future amortization expense related to intangible assets is as follows:

 

For the fiscal years

ended March 31,

       

2027

  $ 862  

2028

    1,724  

2029

    1,551  

2030

    836  
         
    $ 4,973  

 

12

  

 

NOTE 5 – CONCENTRATIONS

 

During the three and six months ended September 30, 2026, one customer accounted for 38% and 36% of our net revenue, respectively, and our two largest customers together accounted for 47% and 46%, respectively.

 

During the three and six months ended September 30, 2025, two customers accounted for 46% and 47% of our net revenue, respectively, and our two largest customers together accounted for 46% and 47%, respectively.

 

As of September 30, 2026, three customers represented 77% of our gross accounts receivable. As of March 31, 2026, two customers accounted for 51% of our gross accounts receivable.

 

As of September 30, 2025, two customers represented 50% of our gross accounts receivable.

 

As of September 30, 2026, two vendors accounted for over 34% of our accounts payable balance.

 

As of September 30, 2025, one vendor accounted for over 27% of our accounts payable balance.

 

The Company’s customer base is comprised of foreign and domestic entities with diverse demographics. Net revenues from foreign customers for the three and six months ended September 30, 2026 were $108,107 or 11.5% and $215,238 or 11.9%, respectively, and $131,256 or 14.8% and $267,671 or 14.4% for the three and six months ended September 30, 2025, respectively.

 

 

NOTE 6 - DISAGGREGATED REVENUES AND SEGMENT INFORMATION

 

The following tables show the Company's revenues disaggregated by reportable segment and by product and service type:

 

   

Three months Ended September 30,

 
   

2026

   

2025

 

Net Revenue in the US

               

Chemical

  $ 219,247     $ 178,652  

Electronics

    515,901       482,063  

Engineering

    98,416       95,527  
      833,564       756,242  
                 

Net Revenue outside the US

               

Chemical

  $ 108,107     $ 131,256  
      108,107       131,256  
                 

Total Revenues

  $ 941,671     $ 887,498  

 

13

 

   

Six Months Ended September 30,

 
   

2026

   

2025

 

Net Revenue in the US

               

Chemical

  $ 437,976     $ 377,297  

Electronics

    988,891       996,745  

Engineering

    165,821       219,460  
      1,592,688       1,593,502  
                 

Net Revenue outside the US

               

Chemical

    215,238       267,671  
      215,238       267,671  
                 

Total Revenues

  $ 1,807,926     $ 1,861,173  

  

 

NOTE 7 – DUE FROM AFFILIATE 

 

The Company provided $330,090 in engineering services to Qol during the year ended March 31, 2018. This amount is shown net of a $240,965 allowance for credit losses on the balance sheets as of September 30, 2026 and March 31, 2026.

 

 

NOTE 8 – LEASES

 

We lease our office and manufacturing facility under a non-cancellable operating lease, which expires on June 30, 2028. The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of September 30, 2026:

 

For the fiscal year ended:

 

Amount

 

March 31, 2027

  $ 53,436  

March 31, 2028

    106,872  

March 31, 2029 (ends June 30, 2028)

    26,718  
         

Total future minimum lease payments

  $ 187,026  

Less: Amount attributable to imputed interest

    (7,560 )

Present value of future minimum lease payments

  $ 179,466  

 

As of September 30, 2026, weighted average remaining lease term was 1.8 years.

Weighted average discount rate was 5.0%.

 

The lease provides for fixed monthly base rent, which is included in the measurement of the operating lease right-of-use asset and lease liability. The Company also reimburses the landlord for real estate taxes and insurance based on actual costs incurred. These reimbursements are variable lease payments, are expensed as incurred, and are not included in the measurement of the right-of-use asset or lease liability. Rent and real estate tax expense for all facilities for the three and six months ended September 30, 2026 was approximately $40,782 and $78,529, respectively, including variable lease costs of $21,178 and $32,830, respectively.

 

Rent and real estate tax expense for the three and six months ended September 30, 2025 was approximately $37,700 and $76,700, respectively, including variable lease costs of $11,652 and $23,305, respectively.

 

14

 

These are reported as a component of cost of sales and selling, general and administrative expenses in the accompanying statements of operations.

 

 

NOTE 9 – LINE OF CREDIT

 

On June 15, 2018, the Company obtained an unsecured revolving line of credit, with a limit of $400,000. The line expires May 15, 2027, renewing automatically every year. The Company is required to make monthly interest payments, at a variable rate of 7.37% as of September 30, 2026. Any unpaid principal will be due upon maturity. At September 30, 2026 and March 31, 2026, the outstanding balance was $379,293 and $379,446, respectively.

 

 

NOTE 10 – 401(k) RETIREMENT PLAN

 

The Company sponsors a defined contribution 401(k) Retirement Plan (the “Plan”) for its eligible employees. Employees become eligible to participate in the Plan upon meeting certain age and service requirements. Employees may contribute up to the maximum amount allowed by law on a pre-tax basis.

 

The Plan’s investments are recorded at fair value. As of September 30, 2026, Plan assets were diversified across various investment options, including equity funds, fixed income funds, and cash equivalents. During the six months ended September 30, 2026, the Company made matching contributions of $12,582 to the Plan.

 

There were no significant changes to the Plan’s provisions during the year.

 

 

NOTE 11 – LEGAL PROCEEDINGS

 

We are involved, from time to time, in litigation and proceedings arising out of the ordinary course of business. There are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject. 

 

 

NOTE 12 – CONTRACTUAL OBLIGATIONS AND OTHER COMMITMENTS

 

Legal Contingencies

We are involved, from time to time, in litigation and proceedings arising out of the ordinary course of business. There are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject.

 

Product Liability

As of September 30, 2026 and March 31, 2026, there were no claims against us for product liability. 

 

15

  

 

NOTE 13 – FAIR VALUE MEASUREMENTS

 

Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 820, Fair Value Measurements and Disclosures, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under FASB ASC 820 are described as follows:

 

Level 1

Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

   

Level 2

Inputs to the valuation methodology include

 

●Quoted prices for similar assets or liabilities in active markets;

●Quoted prices for identical or similar assets or liabilities in active markets;

●Inputs other than quoted prices that are observable for the asset or liability

●Inputs that are derived principally from or corroborated by observable market data by correlation or other means.

●If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.

   

Level 3

Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The asset's or liability's fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Following is a description of the valuation methodologies used for assets at fair value. There have been no changes in the methodologies used at September 30, 2026.

 

Investments in publicly  held companies are recorded at fair value.

 

Investments in privately held companies are valued at cost, net book value or fair value when available. Investments valued at cost or net book value is a departure from accounting principles generally accepted in the United States of America.

 

The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

 

The following table sets forth by level, within the fair value hierarchy, the Company's assets at fair value as of September 30, 2026:

 

Assets at Fair Value as of September 30, 2026:

 

   

Level 1

   

Level 2

   

Level 3

   

Total

 

Investment

 

$

299,250    

$

-    

$

-    

$

299,250  

TOTAL ASSETS AT FAIR VALUE

 

$

299,250    

$

-    

$

-    

$

299,250  

  

 

NOTE 14 – INCOME TAXES

 

The Company accounts for income taxes under ASC 740, Income Taxes, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and tax bases of assets and liabilities.

 

16

 

Income tax expense

 

Income tax expense (benefit) from continuing operations for the six months ended September 30, 2026, and 2025 consisted of the following:

 

September 30,

 

2026

   

2025

 

Current:

               

State

    2,000       1,500  

Total income tax expense

  $ 2,000     $ 1,500  

 

Deferred income taxes

 

Deferred tax assets and liabilities at September 30, 2026, and 2025 consisted of the following:

 

September 30,

 

2026

   

2025

 

Deferred tax assets:

               

Allowance for doubtful accounts

  $ 255,478     $ 364,969  

Federal net operating loss carryforward

    318,311       282,489  

State net operating loss carryforward

    202,199       177,127  

Federal tax credit carryforwards

    316,772       316,772  

State tax credit carryforwards

    45,366       45,366  

Stock Compensation

    42,715       42,715  

Depreciation – Federal

    239       2,138  

Depreciation – State

    14,834       98,791  

Total deferred tax assets

    1,195,914       1,330,367  

Less: valuation allowance

    (1,195,914 )     (1,330,367 )

Deferred tax liabilities:

               

Depreciation - Federal

    -       -  

Total deferred tax liabilities

    -       -  

Less: valuation allowance

    -       -  

 

The valuation allowance decreased by $43,837 during the six months ended September 30, 2026. Management believes it is more likely than not that the remaining deferred tax assets will not be realized through future taxable income.

 

As of September 30, 2026, the Company has federal net operating loss carryforwards of $1,515,769 and state net operating loss carryforwards of $2,246,650, which may be used to offset future taxable income.

 

Effective tax rate reconciliation

 

The Company’s effective tax rate reconciliation for the six months ended September 30, 2026, and 2025 was as follows:

 

   

% of pretax

income

   

2026

   

% of pretax

income

   

2025

 

Tax at U.S. federal statutory rate (21.0%)

    21.0 %   $ 36,755       21.0 %   $ 45,037  

State and local income taxes, net of federal benefit

    9.0 %     15,752       9.0 %     19,302  

Changes in valuation allowance

    (7.5 %)     (13,151 )     0.5 %     1,200  

Nontaxable or nondeductible items

    21.4 %     (37,356 )     (29.8 %)     (64,039 )

Income tax expense and effective tax rate

    1.1 %   $ 2,000       0.7 %   $ 1,500  

 

The Company pays taxes to only one state – New Jersey.

 

17

 

Income taxes paid

 

Income taxes paid (net of refunds received) for the six months ended September 30, 2026, and 2025 were as follows:

 

September 30,

 

2026

   

2025

 

Total

  $ 500     $ 0  

 

The following jurisdictions individually represented 5% or more of total income taxes paid (net of refunds received) for the six months ended September 30, 2026, and 2025:

 

Jurisdiction

 

2026

   

2025

 

New Jersey

    500       0  

 

Unrecognized tax benefits

 

A reconciliation of the Company’s unrecognized tax benefits for the six months ended September 30, 2026, and 2025 are as follows:

 

September 30,

 

2026

   

2025

 

Unrecognized tax benefits at September 30,

  $ 0     $ 0  

 

At September 30, 2026, and 2025, unrecognized tax benefits that, if recognized, would affect the effective tax rate were $0.

 

Interest and penalties

 

The Company recognizes interest and penalties as a component of selling, general and administrative expenses. Interest and penalties for the six months ended September 30, 2026, and 2025 were $0 and $0, respectively.

 

Open tax years

 

The Company files income tax returns in the United States federal jurisdiction and various state jurisdictions, and in certain foreign jurisdictions. The Company’s federal, state, and foreign income tax returns for tax years after March 31, 2023, for federal and March 31, 2022, for the State of New Jersey remain subject to examination by taxing authorities.

 

 

NOTE 15 – SUBSEQUENT EVENTS

 

Private Placement

 

On October 26, 2026, the Company entered into a Securities Purchase Agreement with certain accredited investors for a private placement of common stock at $0.10 per share, with warrants to purchase additional shares equal to 50% of the shares purchased. The warrants are exercisable at $0.10 per share for five years. The offering targets gross proceeds of approximately $5.0 million and terminates no later than December 31, 2026.

 

On October 27 and 28, 2026, the Company issued a total of 15,500,000 shares of common stock and warrants to purchase 7,750,000 shares, for gross proceeds of $1,550,000. The purchasers include entities affiliated with current and incoming directors.

 

The Company has agreed to reorganize its existing operations into a wholly owned subsidiary and to fund up to $500,000 of the proceeds to that subsidiary. Of that amount, the Company expects to transfer an initial $200,000 from the account holding the offering proceeds to its operating account in the near term. As of the date of this report, that transfer had not occurred.

 

Board of Directors

 

In connection with the private placement, the Board will increase from one to five members. Michael Burychka joined the Board on October 27, 2026. Klaus Kleinfeld and Greg Wasson joined on November 16, 2026, with one seat reserved for an additional independent director. This reconstitution will result in a change in control of the Company.

 

18

  

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our operations and financial condition should be read in conjunction with the condensed financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q. 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-Q to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item 1. Description of Business – Risk Factors" and elsewhere in or incorporated by reference into our Annual Report on Form 10-K for the year ended March 31, 2026.

 

BUSINESS OVERVIEW

 

The Company is a technology-based developer and manufacturer of diversified lines of products and derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; and, research, development, regulatory and engineering services. The Company has increased internal research and development by utilizing their engineering resources to advance their own proprietary medical device technologies.

 

The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM. Sonotron Medical Systems, Inc. (“SMI”), a former wholly owned subsidiary of ADM, had been inactive for several years and was dissolved during the fiscal year ended March 31, 2026, with no material impact on the Company's operations, financial position, or results of operations.

 

RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AS COMPARED TO SEPTEMBER 30, 2025.

 

For the three months ended September 30, 2026

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 327,354     $ 515,901     $ 98,416     $ 941,671  

Cost of Sales

    205,497       208,150       19,136       432,783  

Gross Profit

    121,857       307,751       79,280       508,888  

Gross Profit Percentage

    37 %     60 %     81 %     54 %
                                 

Operating Expenses

    125,640       197,705       38,893       362,238  

Operating Income (Loss)

    (3,783 )     110,046       40,387       146,650  

Other income (expenses)

    (2,983 )     (3,220 )     214       (5,989 )

Income (loss) before benefit from income taxes

  $ (6,766 )   $ 106,826     $ 40,601     $ 140,661  

 

19

 

For the three months ended September 30, 2025

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 309,908     $ 482,063     $ 95,527     $ 887,498  

Cost of Sales

    187,754       275,460       48,487       511,701  

Gross Profit

    122,154       206,603       47,040       375,797  

Gross Profit Percentage

    39 %     43 %     49 %     42 %
                                 

Operating Expenses

    130,631       202,220       40,393       373,244  

Operating Income (Loss)

    (8,477 )     4,383       6,647       2,553  

Other income (expenses)

    (39,855 )     (61,103 )     (16,267 )     (117,225 )

Income (loss) before benefit from income taxes

  $ (48,332 )   $ (56,720 )   $ (9,620 )   $ (114,672 )

 

Variance

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 17,446     $ 33,838     $ 2,889     $ 54,173  

Cost of Sales

    17,743       (67,310 )     (29,351 )     (78,918 )

Gross Profit

    (297 )     101,148       32,240       133,091  

Gross Profit Percentage

    -2 %     17 %     31 %     12 %
                                 

Operating Expenses

    (4,991 )     (4,515 )     (1,500 )     (11,006 )

Operating Income (Loss)

    4,694       105,663       33,740       144,097  

Other income (expenses)

    36,872       57,883       16,481       111,236  

Income (loss) before benefit from income taxes

  $ 41,566     $ 163,546     $ 50,221     $ 255,333  

 

For the six months ended September 30, 2026

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 653,214     $ 988,891     $ 165,821     $ 1,807,926  

Cost of Sales

    436,340       415,609       52,039       903,988  

Gross Profit

    216,874       573,282       113,782       903,938  

Gross Profit Percentage

    33 %     58 %     69 %     50 %
                                 

Operating Expenses

    281,074       425,514       71,355       777,943  

Operating Income (Loss)

    (64,200 )     147,768       42,427       125,995  

Other income (expenses)

    17,714       26,820       4,496       49,030  

Income (loss) before provision for income taxes

  $ (46,486 )   $ 174,588     $ 46,923     $ 175,025  

 

20

 

For the six months ended September 30, 2025

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 644,968     $ 996,745     $ 219,460     $ 1,861,173  

Cost of Sales

    391,057       517,128       95,898       1,004,083  

Gross Profit

    253,911       479,617       123,562       857,090  

Gross Profit Percentage

    39 %     48 %     56 %     46 %
                                 

Operating Expenses

    257,131       399,413       88,759       745,303  

Operating Income (Loss)

    (3,220 )     80,204       34,803       111,787  

Other income (expenses)

    34,910       55,444       12,321       102,675  

Income before provision for income taxes

  $ 31,690     $ 135,648     $ 47,124     $ 214,462  

 

Variance

                               
   

Chemical

   

Electronics

   

Engineering

   

Total

 

Revenue

  $ 8,246     $ (7,854 )   $ (53,639 )   $ (53,247 )

Cost of Sales

    45,283       (101,519 )     (43,859 )     (100,095 )

Gross Profit

    (37,037 )     93,665       (9,780 )     46,848  

Gross Profit Percentage

    -6 %     10 %     12 %     4 %
                                 

Operating Expenses

    23,943       26,101       (17,404 )     32,640  

Operating Income (Loss)

    (60,980 )     67,564       7,624       14,208  

Other income (expenses)

    (17,196 )     (28,624 )     (7,825 )     (53,645 )

Income (loss) before benefit from income taxes

  $ (78,176 )   $ 38,940     $ (201 )   $ (39,437 )

 

Revenues for the three months ended September 30, 2026 increased by $54,173, or 6.1%, compared to the same period in 2025. Chemical segment revenue increased by $17,446 to $327,354, Electronics segment revenue increased by $33,838 to $515,901, and Engineering segment revenue increased by $2,889 to $98,416.

 

Revenues for the six months ended September 30, 2026 decreased by $53,247, or 2.9%, compared to the same period in 2025. Chemical segment revenue increased by $8,246 to $653,214, while Electronics segment revenue decreased by $7,854 to $988,891 and Engineering segment revenue decreased by $53,639, or 24.4%, to $165,821.

 

Gross profit for the three months ended September 30, 2026 increased by $133,091, or 35.4%, compared to the same period in 2025, and gross profit margin increased to 54% from 42%. Electronics gross margin increased to 60% from 43% and Engineering gross margin increased to 81% from 49%, while Chemical gross margin decreased to 37% from 39%.

 

Gross profit for the six months ended September 30, 2026 increased by $46,848, or 5.5%, compared to the same period in 2025, and gross profit margin increased to 50% from 46%. Electronics gross margin increased to 58% from 48% and Engineering gross margin increased to 69% from 56%, while Chemical gross margin decreased to 33% from 39%.

 

Operating expenses for the three months ended September 30, 2026 decreased by $11,006, or 2.9%, compared to the same period in 2025, reflecting decreases of $4,991 in the Chemical segment, $4,515 in the Electronics segment and $1,500 in the Engineering segment. Research and development expenses increased by $24,806 to $121,546, and selling, general and administrative expenses decreased by $35,812 to $240,692.

 

21

 

Operating expenses for the six months ended September 30, 2026 increased by $32,640, or 4.4%, compared to the same period in 2025, reflecting increases of $23,943 in the Chemical segment and $26,101 in the Electronics segment, partially offset by a decrease of $17,404 in the Engineering segment. Selling, general and administrative expenses increased by $30,156 to $553,130, and research and development expenses increased by $2,484 to $224,813.

 

Income from operations for the three months ended September 30, 2026 was $146,650, compared to $2,553 for the same period in 2025, an increase of $144,097. Income from operations for the six months ended September 30, 2026 was $125,995, compared to $111,787 for the same period in 2025, an increase of $14,208.

 

Other income (expense) for the three months ended September 30, 2026 was a net expense of $5,989, compared to a net expense of $117,225 for the same period in 2025, primarily due to an unrealized loss of $750 on the Company’s investment in RetinalGenix in the current period, compared to an unrealized loss of $111,000 in the prior-year period.

 

Other income (expense) for the six months ended September 30, 2026 was net income of $49,030, compared to $102,675 for the same period in 2025. Other income in both periods consists primarily of unrealized gains on the Company’s investment in RetinalGenix of $59,250 and $114,750, respectively. RetinalGenix common stock is thinly traded, and these unrealized gains are not a source of cash. Excluding the unrealized gain, income before provision for income taxes for the six months ended September 30, 2026 would have been $115,775.

 

Income before provision for income taxes was $140,661 for the three months ended September 30, 2026, compared to a loss of $114,672 for the same period in 2025, and $175,025 for the six months ended September 30, 2026, compared to $214,462 for the same period in 2025.

 

We are highly dependent upon certain customers. During the three and six months ended September 30, 2026, one customer accounted for 38% and 36% of our net revenue, respectively, and our two largest customers together accounted for 47% and 46%, respectively. Net revenues from foreign customers for the three and six months ended September 30, 2026 were $108,107 or 11.5% and $215,238 or 11.9%, respectively.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At September 30, 2026, we had cash and cash equivalents of $204,410 as compared to $255,730 at March 31, 2026, a decrease of $51,320. The decrease was attributable to net cash used in operating activities of $51,320, as increases in accounts receivable of $131,738 and inventories of $129,830 and a decrease in accrued expenses and other current liabilities of $22,561 more than offset net income of $173,025 and increases in accounts payable of $73,066 and the bank overdraft of $28,931. Our cash will continue to be used for increased marketing costs, and increased production labor costs all in an attempt to increase our revenue, as well as increased expenditures for our internal R&D. We expect to have enough cash to fund operations for the next twelve months.

 

Below is a summary of our cash flow for the six-month periods indicated:

 

   

September 30,

2026

   

September 30,

2025

 

Net cash provided by (used in) operating activities

  $ (51,320 )   $ (60,849 )

Cash flows provided (used) in financing activities:

    -       (896 )

Net increase (decrease) in cash and cash equivalents

  $ (51,320 )   $ (61,745 )

Cash and cash equivalents - beginning of period

  $ 255,730     $ 382,969  

Cash and cash equivalents - end of period

  $ 204,410     $ 321,224  

 

Future Sources of Liquidity:

 

We expect that growth with profitable customers and continued focus on new customers will enable us to generate cash flows from operating activities during fiscal 2027.

 

22

 

Based on current expectations, we believe that our existing cash and cash equivalents of $204,410 as of September 30, 2026, and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

 

OPERATING ACTIVITIES 

 

Net cash used in operating activities was $51,320 for the six months ended September 30, 2026, as compared to $60,849 for the six months ended September 30, 2025 (as reclassified; see Note 2). Operating cash flow for the current period reflects a $131,738 increase in accounts receivable, a $129,830 increase in inventories and a $22,561 decrease in accrued expenses and other current liabilities, partially offset by increases of $73,066 in accounts payable, $28,931 in the bank overdraft and $14,853 in customer deposits.

 

INVESTING ACTIVITIES

 

There were no investing activities during the six months ended September 30, 2026 or 2025.

 

FINANCING ACTIVITIES

 

There were no financing activities during the six months ended September 30, 2026. For the six months ended September 30, 2025, net cash used in financing activities was $896, consisting of payments on the PPP loan (as reclassified; see Note 2).

 

OFF BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Concentration of Credit Risk

 

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and investments.

 

Cash and cash equivalents – For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held at these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of $250,000. At September 30, 2026, cash and cash equivalents were within the FDIC insured limit.

 

Investments in publicly held companies are recorded at fair value. Investments in privately held companies are valued at cost, net book value or fair value, when available. Investment value at cost or net book value is a departure from accounting principles generally accepted in the United States of America. For the six months ended September 30, 2026, the valuation of the publicly held company increased by $59,250, including a decrease of $750 during the three months ended September 30, 2026.

 

Our sales are materially dependent on a small group of customers, as noted in Note 5 of our condensed financial statements. We monitor our credit risk associated with our receivables on a routine basis. We also maintain credit controls for evaluating and granting customer credit. 

 

23

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

The Company's management, including the Company's principal executive officer and principal financial officer, have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Based upon their evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective for the purpose of ensuring that the information required to be disclosed in the reports that the Company files or submits under the Exchange Act with the Securities and Exchange Commission (the "SEC") (1) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. During the quarterly and year-to-date period ended September 30, 2026, there were no changes in the Company's internal control over financial reporting which materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting. 

 

The determination that our disclosure controls and procedures were not effective as of September 30, 2026, is a result of:

 

a. Deficiencies in Internal Control Structure Environment. During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.  

 

b. Inadequate staffing and supervision within the accounting operations of our company. The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews.  The Company’s plan is to expand its accounting operations as the business of the Company expands. 

 

The Company believes that the financial statements present fairly, in all material respects, the Company’s condensed balance sheets as of September 30, 2026, and March 31, 2026 and the related condensed statements of operations, and cash flows for the three and six months ended September 30, 2026 and 2025, in conformity with generally accepted accounting principles, notwithstanding the material weaknesses we identified.

 

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended March 31, 2026. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None 

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

 

ITEM 5. OTHER INFORMATION

 

None 

 

 

ITEM 6. EXHIBITS.

 

(a) Exhibit No.

 

   

31.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

   

32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

   

101.INS**

Inline XBRL Instance

101.SCH**

Inline XBRL Taxonomy Extension Schema

101.CAL**

Inline XBRL Taxonomy Extension Calculation

101.DEF**

Inline XBRL Taxonomy Extension Definition

101.LAB**

Inline XBRL Taxonomy Extension Labels

101.PRE**

Inline XBRL Taxonomy Extension Presentation

104

Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

 

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

25

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ADM TRONICS UNLIMITED, INC.

(Registrant)

 
       
       
 

By:

/s/ Andre' DiMino

 
   

Andre' DiMino, Chief Executive

 
   

Officer and Chief Financial

Officer

 

 

Dated:

Northvale, New Jersey

 

November 16, 2026

 

26

Keep reading